Overview
Pulmonary nodular lymphoid hyperplasia (PNLH) is a rare, benign condition where clusters of immune cells called lymphocytes grow and form small nodules (lumps) in the lung tissue. It is sometimes called pulmonary lymphoid hyperplasia or nodular lymphoid lesion of the lung. These nodules are not cancerous, but they can look similar to other lung conditions on scans, which makes diagnosis tricky. The condition belongs to a group of lung disorders involving abnormal but non-cancerous growth of lymphoid (immune) tissue. Many people with PNLH have no symptoms at all and the nodules are found by accident during a chest X-ray or CT scan done for another reason. When symptoms do occur, they can include a mild cough, shortness of breath, or a general feeling of chest discomfort. Some patients have an underlying autoimmune condition or immune system problem, such as Sjögren's syndrome or common variable immunodeficiency (CVID), which may be linked to the development of PNLH. Treatment depends on how severe the condition is and whether symptoms are present. Many patients are simply monitored over time with regular imaging. When treatment is needed, corticosteroids (anti-inflammatory medicines) are often used. In some cases, the nodules are surgically removed, both to confirm the diagnosis and to treat the condition. The overall outlook is generally good, especially when there is no underlying serious immune disorder. Regular follow-up with a lung specialist is important to watch for any changes.
Also known as:
Key symptoms:
Persistent dry coughShortness of breath, especially with activityMild chest discomfort or tightnessFatigue or low energyAccidental finding on chest X-ray or CT scan with no symptomsOccasional low-grade feverUnintentional weight loss in some casesReduced exercise tolerance
Clinical phenotype terms (10)— hover any for plain English
Sporadic
Usually appears on its own, not inherited from a parent
Adult
Begins in adulthood (age 18 or older)
Treatments
No FDA-approved treatments are currently listed for Pulmonary nodular lymphoid hyperplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pulmonary nodular lymphoid hyperplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Pulmonary nodular lymphoid hyperplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pulmonary nodular lymphoid hyperplasia.
Community
No community posts yet. Be the first to share your experience with Pulmonary nodular lymphoid hyperplasia.
Start the conversation →Latest news about Pulmonary nodular lymphoid hyperplasia
No recent news articles for Pulmonary nodular lymphoid hyperplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Is my diagnosis of PNLH confirmed by biopsy, and has lymphoma been fully ruled out?,Do I need treatment right now, or is a watch-and-wait approach appropriate for me?,Should I be tested for an underlying autoimmune condition or immune deficiency?,How often do I need follow-up CT scans, and what changes should prompt me to call you sooner?,What symptoms should make me go to the emergency room?,Are there any clinical trials or specialist centers I should consider?,Will this condition affect my ability to work or exercise long-term?
Common questions about Pulmonary nodular lymphoid hyperplasia
What is Pulmonary nodular lymphoid hyperplasia?
Pulmonary nodular lymphoid hyperplasia (PNLH) is a rare, benign condition where clusters of immune cells called lymphocytes grow and form small nodules (lumps) in the lung tissue. It is sometimes called pulmonary lymphoid hyperplasia or nodular lymphoid lesion of the lung. These nodules are not cancerous, but they can look similar to other lung conditions on scans, which makes diagnosis tricky. The condition belongs to a group of lung disorders involving abnormal but non-cancerous growth of lymphoid (immune) tissue. Many people with PNLH have no symptoms at all and the nodules are found by ac
How is Pulmonary nodular lymphoid hyperplasia inherited?
Pulmonary nodular lymphoid hyperplasia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Pulmonary nodular lymphoid hyperplasia typically begin?
Typical onset of Pulmonary nodular lymphoid hyperplasia is adult. Age of onset can vary across affected individuals.